SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma.
SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma.
复制标题
SMARCC2通过染色质重塑介导转录因子EGR1对DKK1的调节,降低胶质母细胞瘤的增殖能力
DOI:
10.1038/s41419-022-05439-8
复制
发表时间:
2022-11-23
影响因子:
9
通讯作者:
Zhou, Qiang
中科院分区:
文献类型:
--
作者:
Li, Chiyang;Wang, Tong;Gu, Junwei;Qi, Songtao;Li, Junjie;Chen, Lei;Wu, Hang;Shi, Linyong;Song, Chong;Li, Hong;Zhu, Liwen;Lu, Yuntao;Zhou, Qiang
Switch/sucrose-nonfermenting (SWI/SNF) complexes play a key role in chromatin remodeling. Recent studies have found that SMARCC2, as the core subunit of the fundamental module of the complex, plays a key role in its early assembly. In this study, we found a unique function of SMARCC2 in inhibiting the progression of glioblastoma by targeting the DKK1 signaling axis. Low expression of SMARCC2 is found in malignant glioblastoma (GBM) compared with low-grade gliomas. SMARCC2 knockout promoted the proliferation of glioblastoma cells, while its overexpression showed the opposite effect. Mechanistically, SMARCC2 negatively regulates transcription by dynamically regulating the chromatin structure and closing the promoter region of the target gene DKK1, which can be bound by the transcription factor EGR1. DKK1 knockdown significantly reduced the proliferation of glioblastoma cell lines by inhibiting the PI3K–AKT pathway. We also studied the functions of the SWIRM and SANT domains of SMARCC2 and found that the SWIRM domain plays a more important role in the complete chromatin remodeling function of SMARCC2. In addition, in vivo studies confirmed that overexpression of SMARCC2 could significantly inhibit the size of intracranial gliomas in situ in nude mice. Overall, this study shows that SMARCC2, as a tumor suppressor, inhibits the proliferation of glioblastoma by targeting the transcription of the oncogene DKK1 through chromatin remodeling, indicating that SMARCC2 is a potentially attractive therapeutic target in glioblastoma.
登录
查看更多内容
影响因子:
21.3
作者:
Garry GA;Bezprozvannaya S;Chen K;Zhou H;Hashimoto H;Morales MG;Liu N;Bassel-Duby R;Olson EN
通讯作者:
Olson EN
影响因子:
37.3
作者:
Chen L;Li M;Li Q;Wang CJ;Xie SQ
通讯作者:
Xie SQ
影响因子:
33.5
作者:
Chen G;Zhou H;Liu B;Wang Y;Zhao J;Giancotti FG;Long J
通讯作者:
Long J
影响因子:
9
作者:
Di M;Wang L;Li M;Zhang Y;Liu X;Zeng R;Wang H;Chen Y;Chen W;Zhang Y;Zhang M
通讯作者:
Zhang M
影响因子:
8.8
作者:
Narayanan, Ramanathan;Pirouz, Mehdi;Tuoc, Tran
通讯作者:
Tuoc, Tran